News from the Scientific Community Links

Cancer in general

• Hallmarks of Cancer: New Dimensions
• Precision Oncology: Between Vaguely Right and Precisely Wrong

Current (gene-based) approaches to Precision Oncology

• Estimation of the Percentage of US Patients With Cancer Who Benefit From Genome-Driven Oncology
• Molecular Landscape and Actionable Alterations in a Genomically Guided Cancer Clinical Trial: National Cancer Institute Molecular Analysis for Therapy Choice (NCI-MATCH)
• Molecular screening to select therapy for advanced cancer?
• Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020

Decision-making in Healthcare

• The ecosystem of health decision making: from fragmentation to synergy

Functional drug sensitivity testing

• Functional Drug Screening in the Era of Precision Medicine
• Functional precision oncology: Testing tumors with drugs to identify vulnerabilities and novel combinations
• Patient-derived organoids as a predictive biomarker for treatment response in cancer patients
• Precision Medicine in Oncology: In Vitro Drug Sensitivity and Resistance Test (DSRT) for Selection of Personalized Anticancer Therapy

Guidelines

• Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up